BrainCheck

Based in Houston, Texas, BrainCheck provides an FDA-registered mobile cognitive assessment and care management platform that helps physicians detect early signs of dementia and mild cognitive impairment. Founded in 2015 by Yael Katz and David Eagleman, the healthcare technology company offers a SaaS platform utilized by more than 400 clinical practices, health systems, and athletic organizations. This Class II medical device delivers rapid, personalized cognitive testing with clinical reimbursement support and has been used to monitor over 150,000 individuals worldwide. The organization has raised $20 million in total funding, including a $10 million Series B round backed by Next Coast Ventures, S3 Ventures, and True Wealth Ventures. Recently, the company expanded its executive leadership team by appointing Chris Loughlin as Chief Executive Officer, Trey Swain as Chief Financial Officer, and Matthew Cerullo as Chief Revenue Officer.

BrainCheck is a digital health technology company that builds rapid, mobile cognitive assessment and decision support tools for healthcare providers. Its platform enables physicians to screen, assess, and monitor cognitive health efficiently, helping patients live safer, better lives at home while reducing caregiver burden and healthcare costs[1][3][4]. BrainCheck serves healthcare organizations, including over 100 healthcare and athletic institutions, and more than 40,000 individuals use its tools to track cognitive function and share results with their doctors[1]. The company addresses the critical problem of early detection and management of cognitive impairment, a growing public health concern, by providing a fully digital, FDA-registered Class II medical device solution that integrates into clinical workflows[1][4]. BrainCheck has demonstrated strong growth momentum, supported by multiple funding rounds totaling over $39 million and recognition such as the Care Management Innovation Award in 2024[2].

BrainCheck was founded in 2015 by Dr. Yael Katz, a neuroscientist with expertise in computational neuroscience and data analytics, who combined her scientific background and entrepreneurial experience to create a scalable solution for personalized cognitive healthcare[1]. The idea emerged from her desire to leverage her unique skills to solve a pressing healthcare challenge—enabling physicians to deliver high-quality, person-centered cognitive care at scale[1]. Early traction came from rigorous research spanning over 20 years and adoption by healthcare providers seeking efficient cognitive assessment tools[1].

Core Differentiators

• Comprehensive Digital Platform: BrainCheck offers an all-in-one cognitive assessment and care planning toolset that supports screening, monitoring, and personalized intervention from any device and location[3][4].
• FDA-Registered Medical Device: The platform is registered as a Class II medical device, ensuring regulatory compliance and clinical reliability[1].
• Data-Driven and Validated: The assessments are backed by over two decades of research, providing physicians with validated, actionable insights to inform care decisions[1][3].
• User-Centric Design: BrainCheck emphasizes ease of use for providers, patients, and caregivers, integrating smoothly into clinical workflows and enabling remote cognitive health monitoring[3][4].
• Strong Clinical and Market Adoption: Used by over 100 healthcare organizations and tens of thousands of individuals, demonstrating trust and scalability[1][2].

Role in the Broader Tech Landscape

BrainCheck rides the rising trend of digital health innovation focused on cognitive care, a field gaining urgency due to the increasing prevalence of cognitive impairments such as mild cognitive impairment and dementia. The timing is critical as healthcare systems seek scalable, cost-effective solutions to address cognitive decline early, improving outcomes and reducing long-term costs[1][4]. BrainCheck’s technology aligns with broader market forces emphasizing telehealth, personalized medicine, and data-driven clinical decision support. By enabling routine cognitive screening and monitoring, BrainCheck helps close the gap between cognitive impairment prevalence and diagnosis, influencing the ecosystem toward proactive brain health management[3][4].

Quick Take & Future Outlook

Looking ahead, BrainCheck is positioned to expand its impact by deepening integration with healthcare providers and broadening its user base, potentially incorporating advanced analytics and AI to enhance predictive capabilities. Trends such as aging populations, increased awareness of brain health, and healthcare digitization will shape its trajectory. BrainCheck’s influence may evolve from a cognitive assessment tool to a comprehensive brain health platform, driving earlier interventions and personalized care pathways. Its mission to make cognitive health a routine part of wellness visits could transform standards of care and patient outcomes in neurology and primary care[3][4].

In summary, BrainCheck leverages cutting-edge neuroscience and technology to empower providers and patients with accessible, validated cognitive health tools, addressing a critical healthcare need with growing urgency and market demand.